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Clinical PerspectiveWhat Is New?This study addresses how subsequent hospitalizations after an acute myocardial infarction may influence the risk of a recurrent acute myocardial infarction.We show that many types of subsequent hospitalizations can increase the risk of a recurrent acute myocardial infarction.We are introducing the idea of dynamic risk prediction, in which subsequent events influence the likelihood of a future cardiovascular event.What Are the Clinical Implications?Risk‐stratification after an acute myocardial infarction is necessary to inform the choice of clinical strategies.We are showing that risk prediction should be updated as new information becomes available. In this case, subsequent hospitalizations modify risk.This study indicates the need to develop dynamic risk calculators that can be updated over time.

 {#jah34948-sec-0008}

Nonstandard Abbreviations and AcronymsAMI acute myocardial infarctionCABG coronary artery bypass graftingCAD coronary artery diseaseCATH cardiac catheterizationCCS Clinical Classifications SoftwareCOPD chronic obstructive pulmonary diseaseDM diabetes mellitusFY fiscal yearsHR hazard ratioHTN hypertension*ICD‐9‐CM International Classification of Diseases, Ninth Revision, Clinical Modification*IQR interquartile rangePCI percutaneous coronary interventionUTI urinary tract infection

 {#jah34948-sec-0009}

Despite the marked decline in the rate of recurrent AMI over recent decades,[1](#jah34948-bib-0001){ref-type="ref"}, [2](#jah34948-bib-0002){ref-type="ref"}, [3](#jah34948-bib-0003){ref-type="ref"}, [4](#jah34948-bib-0004){ref-type="ref"}, [5](#jah34948-bib-0005){ref-type="ref"} recurrence remains a significant threat to AMI survivors. Classifying patients according to their risk of recurrent AMI may be helpful in efforts to prevent the next AMI. Although patient baseline characteristics, postdischarge lifestyle, quality of care, and medication adherence are associated with risk of recurrent AMI,[6](#jah34948-bib-0006){ref-type="ref"}, [7](#jah34948-bib-0007){ref-type="ref"}, [8](#jah34948-bib-0008){ref-type="ref"}, [9](#jah34948-bib-0009){ref-type="ref"}, [10](#jah34948-bib-0010){ref-type="ref"} subsequent hospitalizations after the initial AMI may also increase the risk of recurrence and, therefore, may be important when considering a patient\'s risk. Identifying subsequent hospitalizations associated with recurrent AMI could better inform patients, families, and physicians about any further increases in the risk of recurrent AMI and help ensure intensive follow‐up and risk modification behaviors.

Efforts to identify risk markers and risk factors for long‐term outcomes after AMI have focused on patient characteristics available at the time of the initial hospitalization for AMI.[8](#jah34948-bib-0008){ref-type="ref"}, [11](#jah34948-bib-0011){ref-type="ref"}, [12](#jah34948-bib-0012){ref-type="ref"} Identification of postdischarge events as risk markers for adverse outcomes is limited, and many of the available data focus on mortality.[13](#jah34948-bib-0013){ref-type="ref"}, [14](#jah34948-bib-0014){ref-type="ref"}, [15](#jah34948-bib-0015){ref-type="ref"}, [16](#jah34948-bib-0016){ref-type="ref"} There is scant information on the association between subsequent hospitalizations and recurrent AMI. A comprehensive, contemporary, national evaluation of such rehospitalizations could provide important information for the prevention of recurrent AMI, particularly among Medicare beneficiaries who are a high‐risk population for AMI.

Accordingly, we used national Medicare inpatient claims data to assess the association between subsequent hospitalizations and recurrent AMI within 1 year after an initial AMI and identify clinically important hospitalizations that increased the risk of recurrence. This study, which was based on 100% national data and detailed follow‐up information about patients with AMI, is ideally positioned to generate information to update risk stratification for recurrent AMI in the year after hospital discharge.

Methods {#jah34948-sec-0010}
=======

Restricted by our Data Use Agreement with the Centers for Medicare & Medicaid Services (CMS), the Medicare data used for this study cannot be made publicly available to other researchers for purposes of reproducing the results or replicating the procedure. However, Medicare data are available from the Centers for Medicare & Medicaid Services upon request (<https://www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order/Data-Disclosures-Data-Agreements/DUA_-_Forms.html>).

Study Sample {#jah34948-sec-0011}
------------

We used the Centers for Medicare & Medicaid Services Medicare denominator files to identify all beneficiaries aged 65 years or older enrolled in the fee‐for‐service program for at least 12 months in fiscal years (FY) 2009--2014 (October 1, 2008 to September 31, 2014), a period in which all diagnosis codes were classified according to the *International Classification of Diseases, Ninth Revision, Clinical Modification* (*ICD‐9‐CM*). We linked these enrollment data to Medicare fee‐for‐service inpatient claims to identify beneficiaries who were discharged alive after hospitalization for AMI at an acute‐care hospital in the United States. This was designated the index AMI hospitalization. If a patient had \>1 AMI hospitalization during the study period, we selected the first AMI during the study period as the index AMI. Data from FY 2008 were used to identify patients who were rehospitalized with AMI in FY 2009; FY 2015 data were used to ensure 1 year of follow‐up for patients hospitalized with AMI during FY 2014.

AMI was defined as an *ICD‐9‐CM* principal discharge diagnosis code of 410.xx. We excluded patients with *ICD‐9‐CM* codes 410.x2 because the codes represent subsequent episodes of care related to the index AMI. We also excluded patients who had a length of stay ≤1 day (because these patients were unlikely to have had an AMI), had conflicting dates of death and hospitalization, or were subsequently transferred to another acute‐care hospital for continuing care after the initial AMI.

Patient Baseline Characteristics {#jah34948-sec-0012}
--------------------------------

Patient baseline characteristics included age (continuous), sex, race (white, black, other), and clinical comorbidities identified using the method employed by the Centers for Medicare & Medicaid Services to profile hospital 30‐day mortality measures for AMI.[17](#jah34948-bib-0017){ref-type="ref"} We determined comorbidities from secondary diagnosis codes for the index AMI hospitalization as well as the principal and secondary diagnosis codes from all hospitalizations during the 12 months before the index AMI. Because the maximum number of diagnosis codes in Medicare data increased from 10 to 25 in 2011,[18](#jah34948-bib-0018){ref-type="ref"} we restricted the 2011--2015 data to the first 10 diagnosis codes to calculate comorbidities.

Outcome {#jah34948-sec-0013}
-------

The primary outcome was recurrent AMI within 1 year of discharge for the initial AMI. For patients with \>1 recurrent AMI, the first recurrence was selected. Deaths during the 1‐year follow‐up period without a recurrent AMI hospitalization were treated as competing risks in the analysis. Secondary outcomes included 30‐day all‐cause mortality, 30‐day all‐cause readmission, and 1‐year all‐cause mortality using the index AMI discharge as the time zero. Mean length of stay and mean Medicare payment for the index AMI hospitalization were also assessed.

Subsequent Hospitalizations {#jah34948-sec-0014}
---------------------------

We identified all subsequent hospitalizations within 1 year after discharge for the initial AMI. For patients with a recurrent AMI, subsequent hospitalizations were restricted to the period prior to the recurrent AMI. Because of the large volume of individual *ICD‐9‐CM* codes, we used the Clinical Classifications Software (CCS),[19](#jah34948-bib-0019){ref-type="ref"} a diagnosis and procedure categorization algorithm developed by the Agency for Healthcare Research and Quality, to characterize the subsequent hospitalizations. Using the CCS single‐level diagnosis‐specific algorithm, we collapsed \>14 000 individual *ICD‐9‐CM* principal discharge diagnosis codes into 285 clinically homogeneous, meaningful, and mutually exclusive disease categories ([Table S1](#jah34948-sup-0001){ref-type="supplementary-material"}). If a patient had \>1 hospitalization for the same disease category, the first one was selected. We excluded CCS hospitalizations that occurred at a frequency \<1% to avoid counting hospitalizations for less frequent diseases in the Medicare population.

Statistical Analysis {#jah34948-sec-0015}
--------------------

We divided patients into 2 samples, 2009--2011 and 2012--2014. We used the first sample to conduct the main analysis and the second to confirm the findings. We compared baseline characteristics between patients who had a recurrent AMI and those who did not have a recurrent AMI using the chi‐squared test for categorical variables and the t test for continuous variables. Using the 2009--2011 sample, for each patient, we estimated the baseline risk at the time of discharge of having a recurrent AMI within 1 year after discharge by fitting a Cox proportional hazards model with Markov Chain Monte Carlo simulations that modeled time to first recurrent AMI as a function of a patient\'s baseline characteristics described above. The model also included in‐hospital treatments (percutaneous coronary intervention, coronary artery bypass grafting, and cardiac catheterization), length of stay, and discharge to home (yes/no) because these variables may be associated with the outcome. We retained a variable in the model if the posterior probability of its nonzero coefficient was \>0.95. We used the regression coefficients estimated from this model to calculate a baseline risk score for recurrent AMI for each patient. We standardized the score through the *Z* score method and stratified patients into 1 of 3 risk groups based on the risk score distribution: low (\<10th percentile), average (10th--90th percentile), and high (\>90th percentile). The baseline risk group represented a patient\'s risk of recurrent AMI at discharge. We used variables selected using the 2009--2011 data to calculate the score for patients in the 2012--2014 data as well.

We fit a single‐variable Cox regression model to describe the observed relationship between 1‐year recurrent AMI and a CCS‐specific condition‐related subsequent hospitalization, without accounting for patient baseline risk of recurrence. The time a hospitalization occurred was used as a time‐varying variable in the analysis. We repeated this analysis for each of the potential subsequent hospitalizations. To further assess the association between rehospitalizations and 1‐year recurrent AMI, we fit the Cox regression model with Markov Chain Monte Carlo simulations that modeled recurrent AMI as a function of all potential subsequent hospitalizations (event, yes/no, and time) as time‐varying variables, adjusted for the patient baseline risk score for recurrent AMI. We retained a rehospitalization in the model if the posterior probability of its nonzero coefficient was \>0.95. To further assess the change in risk of recurrent AMI between patients with and without at least 1 subsequent rehospitalization, we fit the Cox model with a binary time‐varying indicator (1=had ≤1 subsequent CCS‐specific condition‐related rehospitalizations; 0=no rehospitalization), stratified by baseline risk group and further by age group. If a patient had \>1 CCS‐specific condition‐related rehospitalization, the time that the first event occurred was used for the model.

Analyses were conducted using SAS version 9.4, 64‐bit Windows (SAS Institute Inc., Cary, NC). As of 2019, the data were 5 years old. Analyses were repeated using the 2012--2014 data. Deaths before recurrent AMI were addressed using the Fine and Gray[20](#jah34948-bib-0020){ref-type="ref"} method for competing risks. The Lee, Wei, and Amato method[21](#jah34948-bib-0021){ref-type="ref"} of robust sandwich variance matrix estimation was used to adjust for within‐hospital clustering of patients. All statistical testing was 2‐sided, and *P*\<0.05 was considered statistically significant. The study followed the guidelines for cohort studies described in the Strengthening the Reporting of Observational Studies in Epidemiology Statement: Guidelines for Reporting Observational Studies.[22](#jah34948-bib-0022){ref-type="ref"} The Yale University Institutional Review Board reviewed the study protocol and granted a waiver of informed consent for the use of the deidentified database.

Results {#jah34948-sec-0016}
=======

Study Sample and Patient Baseline Characteristics {#jah34948-sec-0017}
-------------------------------------------------

The study included 884 931 (447 690 in 2009--2011 and 437 241 in 2012--2014) unique patients who were discharged alive after AMI, were not transferred to another acute‐care hospital, and were hospitalized for \>1 day during their index admission. Overall, patients had a mean age of 78.0 (SD, 8.6) years, and 47.7% were female. The most common comorbidities were chronic atherosclerosis (73.3%), hypertension (67.9%), diabetes mellitus (32.1%), and anemia (25.2%). During the index AMI hospitalization, 42.2% of patients had a percutaneous coronary intervention, 9.1% underwent coronary artery bypass grafting, and 58.2% had cardiac catheterization. The median length of stay was 4 (interquartile range \[IQR\], 2--7) days, and 57.5% of patients were discharged to home. Patient characteristics were no different between the 2009--2011 and 2012--2014 samples (Table [1](#jah34948-tbl-0001){ref-type="table"}).

###### 

Patient Baseline Characteristics by Study Sample

                                                           Fiscal Year 2009--2011   Fiscal Year 2012--2014                                                            
  -------------------------------------------------------- ------------------------ ------------------------ ------------------ ------------------ ------------------ ------------------
  Demographics, n (%)                                                                                                                                                 
  Age, mean (SD)                                           78.3 (8.6)               78.2 (8.5)               79.1 (9.0)         77.8 (8.6)         77.8 (8.6)         78.3 (9.0)
  Female                                                   218 034 (48.7)           207 463 (48.7)           10 571 (49.7)      204 361 (46.7)     195 846 (46.7)     8515 (47.0)
  White                                                    391 029 (87.3)           373 133 (87.5)           17 896 (84.2)      378 338 (86.5)     363 327 (86.7)     15 011 (82.8)
  Black                                                    35 049 (7.8)             32 874 (7.7)             2175 (10.2)        35 158 (8.0)       33 234 (7.9)       1924 (10.6)
  Other                                                    21 612 (4.8)             20 419 (4.8)             1193 (5.6)         23 745 (5.4)       22 559 (5.4)       1186 (6.5)
  Prior cardiovascular events, n (%)                                                                                                                                  
  Heart failure                                            57 891 (12.9)            53 063 (12.4)            4828 (22.7)        52 783 (12.1)      48 970 (11.7)      3813 (21.0)
  AMI                                                      18 926 (4.2)             16 607 (3.9)             2319 (10.9)        17 917 (4.1)       15 946 (3.8)       1971 (10.9)
  Unstable angina                                          11 499 (2.6)             10 219 (2.4)             1280 (6.0)         10 356 (2.4)       9375 (2.2)         981 (5.4)
  Chronic atherosclerosis                                  326 924 (73.0)           310 783 (72.9)           16 141 (75.9)      322 038 (73.7)     308 135 (73.5)     13 903 (76.7)
  Cardiopulmonary respiratory failure or shock             20 232 (4.5)             18 717 (4.4)             1515 (7.1)         21 444 (4.9)       20 102 (4.8)       1342 (7.4)
  Anterior MI (*ICD‐9* 410.00--410.19)                     40 964 (9.2)             39 685 (9.3)             1279 (6.0)         36 106 (8.3)       35 157 (8.4)       949 (5.2)
  Inferior/lateral/posterior MI (*ICD‐9* 410.20--410.69)   60 244 (13.5)            58 556 (13.7)            1688 (7.9)         56 186 (12.9)      54 903 (13.1)      1283 (7.1)
  Comorbidities, n (%)                                                                                                                                                
  Hypertension                                             299 244 (66.8)           284 380 (66.7)           14 864 (69.9)      301 284 (68.9)     288 320 (68.8)     12 964 (71.5)
  Stroke                                                   17 964 (1.8)             16 798 (1.8)             1166 (2.3)         16 651 (1.7)       15 600 (1.7)       1051 (2.3)
  Cerebrovascular disease                                  57 891 (4.0)             53 063 (3.9)             4828 (5.5)         52 783 (3.8)       48 970 (3.7)       3813 (5.8)
  Renal failure                                            52 288 (11.7)            47 971 (11.2)            4317 (20.3)        54 285 (12.4)      50 429 (12.0)      3856 (21.3)
  COPD                                                     88 711 (19.8)            83 582 (19.6)            5129 (24.1)        85 379 (19.5)      81 060 (19.3)      4319 (23.8)
  Pneumonia                                                64 817 (14.5)            61 108 (14.3)            3709 (17.4)        58 620 (13.4)      55 605 (13.3)      3015 (16.6)
  Protein‐calorie malnutrition                             21 010 (4.7)             20 090 (4.7)             920 (4.3)          21 924 (5.0)       21 057 (5.0)       867 (4.8)
  Dementia                                                 48 997 (10.9)            46 521 (10.9)            2476 (11.6)        24 691 (5.6)       23 583 (5.6)       1108 (6.1)
  Functional disability                                    10 927 (2.4)             10 182 (2.4)             745 (3.5)          10 552 (2.4)       9908 (2.4)         644 (3.6)
  Peripheral vascular disease                              27 609 (6.2)             25 358 (5.9)             2251 (10.6)        24 431 (5.6)       22 712 (5.4)       1719 (9.5)
  Metastatic cancer                                        29 141 (6.5)             27 664 (6.5)             1477 (6.9)         27 341 (6.3)       26 094 (6.2)       1247 (6.9)
  Major trauma in past year                                26 039 (5.8)             24 762 (5.8)             1277 (6.0)         22 871 (5.2)       21 951 (5.2)       920 (5.1)
  Major psychiatric disorder                               9417 (2.1)               8867 (2.1)               550 (2.6)          9679 (2.2)         9210 (2.2)         469 (2.6)
  Chronic liver disease                                    3009 (0.7)               2835 (0.7)               174 (0.8)          3446 (0.8)         3282 (0.8)         164 (0.9)
  Depression                                               25 098 (5.6)             23 821 (5.6)             1277 (6.0)         26 353 (6.0)       25 187 (6.0)       1166 (6.4)
  Diabetes mellitus                                        139 047 (31.1)           130 064 (30.5)           8983 (42.2)        144 787 (33.1)     136 443 (32.6)     8344 (46.0)
  Parkinson or Huntington disease                          6186 (1.4)               5845 (1.4)               341 (1.6)          6045 (1.4)         5771 (1.4)         274 (1.5)
  Anemia                                                   11 0791 (24.7)           104 398 (24.5)           6393 (30.1)        112 477 (25.7)     106 785 (25.5)     5692 (31.4)
  Asthma                                                   10 699 (2.4)             10 178 (2.4)             521 (2.5)          11 153 (2.6)       10 681 (2.5)       472 (2.6)
  In‐hospital procedures, n (%)                                                                                                                                       
  Percutaneous coronary intervention                       181 125 (40.5)           174 586 (40.9)           6539 (30.8)        192 090 (43.9)     185 794 (44.3)     6296 (34.7)
  Coronary artery bypass grafting                          41 365 (9.2)             40 676 (9.5)             689 (3.2)          39 558 (9.0)       38 948 (9.3)       610 (3.4)
  Cardiac catheterization                                  260 515 (58.2)           250 689 (58.8)           9826 (46.2)        263 534 (60.3)     254 605 (60.7)     8929 (49.3)
  Discharge disposition, n (%)                                                                                                                                        
  Home                                                     253 528 (56.6)           241 745 (56.7)           11 783 (55.4)      255 527 (58.4)     245 028 (58.5)     10 499 (57.9)
  Home with care                                           69 802 (15.6)            65 712 (15.4)            4090 (19.2)        66 388 (15.2)      63 034 (15.0)      3354 (18.5)
  Skilled nursing facility or intermediate care facility   84 997 (19.0)            80 767 (18.9)            4230 (19.9)        76 120 (17.4)      72 897 (17.4)      3223 (17.8)
  Outcome                                                                                                                                                             
  Length of stay, mean (SD) days                           6 (5.4)                  6 (5.5)                  5 (4.6)            5 (5.1)            5 (5.1)            5 (4.2)
  Medicare payment, median (IQR), \$1000                   10.8 (8.3--16.1)         10.8 (8.4--16.2)         10.3 (7.1--14.2)   11.1 (8.5--16.7)   11.1 (8.5--16.8)   10.4 (7.1--14.8)
  30‐day mortality after discharge, n (%)                  23 061 (5.2)             22 487 (5.3)             574 (2.7)          21 743 (5.0)       21 240 (5.1)       503 (2.8)
  1‐year mortality after discharge, n (%)                  86 692 (19.4)            81 729 (19.2)            4963 (23.3)        76 542 (17.5)      72 639 (17.3)      3903 (21.5)
  30‐day all‐cause readmission after discharge, n (%)      85 234 (19.0)            76 967 (18.1)            8270 (38.9)        72 910 (16.7)      65 913 (15.7)      6997 (38.6)

AMI indicates acute myocardial infarction; COPD, chronic obstructive pulmonary disease; *ICD‐9*,*International Classification of Diseases, Ninth Revision;* IQR, interquartile range; and MI, myocardial infarction.
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Outcome {#jah34948-sec-0018}
-------

For the 2009--2011 and 2012--2014 samples, the rates of 1‐year recurrent AMI were 5.3% (95% CI, 5.27--5.41) and 4.6% (95% CI, 4.54--4.67), respectively (*P*\<0.001). Among these patients who had a recurrent AMI, the median (IQR) days from discharge to a recurrent AMI was 115 (34--230) for the 2009--2011 sample and 106 (31--217) for the 2012--2014 sample. In the 2009--2011 and 2012--2014 samples, respectively, the median (IQR) survived days among patients who died within 1 year without a recurrent AMI were 56 (20--128) and 53 (19--121), and the median (IQR) survived days among patients who died with a recurrent AMI were 105 (49--188) and 97 (48--179).

All‐cause mortality rates after the index AMI and before a recurrent AMI were 17.5% (95% CI, 17.4--17.6) and 15.7% (95% CI, 15.6--15.8) for the 2009--2011 and 2012--2014 samples, respectively. Compared with patients without a recurrent AMI, patients with a recurrent AMI had a higher 30‐day postdischarge all‐cause mortality rate (5.3% versus 2.7%; *P*\<0.001), higher 30‐day all‐cause readmission rate (38.9% versus 18.1%; *P*\<0.001), higher 1‐year all‐cause mortality rate (23.3% versus 19.2%; *P*\<0.001), lower median Medicare payment (\$10 300 versus \$10 500), and shorter mean (SD) length of stay (5 \[4.6\] days versus 6 \[5.5\] days). These observed outcomes were similar in the 2009--2011 and 2012--2014 samples (Table [1](#jah34948-tbl-0001){ref-type="table"}).

Association Between Patient Baseline Characteristics and Recurrent AMI {#jah34948-sec-0019}
----------------------------------------------------------------------

In the 2009--2011 sample, the 5 baseline characteristics most strongly associated with 1‐year recurrent AMI were AMI before the index admission (hazard ratio \[HR\], 1.8 \[95% CI, 1.76--1.93\]), unstable angina (HR, 1.5 \[95% CI, 1.41--1.59\]), diabetes mellitus (HR, 1.4 \[95% CI, 1.39--1.47\]), chronic atherosclerosis (HR, 1.3 \[95% CI, 1.26--1.35\]), and renal failure (HR, 1.2 \[95% CI, 1.14--1.23\]; Figure [1](#jah34948-fig-0001){ref-type="fig"}). Patients with a standardized risk \<−1.2 times the SD, between −1.2 and 1.2, and \>1.2 were stratified into low‐, average‐, and high‐risk groups, respectively (Figure [2](#jah34948-fig-0002){ref-type="fig"}). The mean (SD) estimated rates of 1‐year recurrent AMI were 1.7% (0.47) for the low‐risk group, 5.1% (2.03) for average risk, and 14.3% (5.31) for high risk. Within a risk group, the rate of recurrence increased with patient age (Figure [3](#jah34948-fig-0003){ref-type="fig"}, top panel). Results were similar for the 2012--2014 sample (Figure [3](#jah34948-fig-0003){ref-type="fig"}, bottom panel).

![Patient baseline characteristics associated with recurrent AMI within 1 year after the initial AMI.AMI indicates acute myocardial infarction; CABG, coronary artery bypass grafting; CATH, cardiac catheterization; COPD, chronic obstructive pulmonary disease; and PCI, percutaneous coronary intervention.](JAH3-9-e014907-g001){#jah34948-fig-0001}

![Distribution of baseline risk of recurrent acute myocardial infarction within 1 year after discharge for AMI.AMI indicates acute myocardial infarction.](JAH3-9-e014907-g002){#jah34948-fig-0002}

![Baseline risk groups of recurrent acute myocardial infarction within 1 year after discharge for AMI.AMI indicates acute myocardial infarction.](JAH3-9-e014907-g003){#jah34948-fig-0003}

Subsequent Hospitalizations {#jah34948-sec-0020}
---------------------------

Among 285 CCS‐specific conditions, 19 occurred in at least 1% of patients and were included in the model for the 2009--2011 sample (Table [2](#jah34948-tbl-0002){ref-type="table"}). The median (IQR) tetrachoric correlations among parts of these conditions were low (0.11 \[95% CI, 0.08--0.16\] in 2009--2011 and 0.12 \[95% CI, 0.09--0.18\] in 2012--2014). The highest correlation occurred between chronic obstructive pulmonary disease and bronchiectasis (CCS‐127) and respiratory failure/insufficiency/arrest (CCS‐131), which was 0.40 in 2009--2011 and 0.41 in 2012--2014. Among 447 690 patients in the 2009--2011 sample, 36.0% (n=161 327) had at least 1 rehospitalization for 1 of these 19 CCS‐specific conditions before a recurrent AMI within 1 year. The 5 most common rehospitalization events were congestive heart failure (CCS‐108, 9.8%), coronary atherosclerosis and other heart disease (CCS‐101, 6.6%), septicemia (CCS‐2, 4.0%), cardiac dysrhythmias (CCS‐106, 3.7%), and pneumonia (CCS‐122, 3.4%). The 5 events that occurred soonest after discharge were complications of surgical procedures or medical care (CCS‐238; median, 53 \[IQR, 12--165\] days), coronary atherosclerosis and other heart disease (CCS‐101; median, 54 \[IQR, 19--154\] days), congestive heart failure (CCS‐108; median, 62 \[IQR, 18--161\] days), respiratory failure/insufficiency/arrest (CCS‐131; median, 88 \[IQR, 28--198\] days), and cardiac dysrhythmias (CCS‐106; median, 90 \[IQR, 25--204\] days; Figure [4](#jah34948-fig-0004){ref-type="fig"}, top panel). The findings were similar for the 2012--2014 sample (Figure [4](#jah34948-fig-0004){ref-type="fig"}, bottom panel). In‐hospital mortality for these CCS‐specific hospitalizations ranged from 0.3% (nonspecific chest pain, CCS‐102) to 21.9% (septicemia, CCS‐2).

###### 

Occurrence of 19 Targeted Types of CCS‐Specific Condition‐Related Subsequent Hospitalizations

  Rehospitalization, N (%)                                                                  FY 2009--2011   FY 2012--2014
  ----------------------------------------------------------------------------------------- --------------- ---------------
  Septicemia (CCS‐2; except in labor)                                                       18 582 (4.2)    19 333 (4.4)
  Diabetes mellitus with complications (CCS‐50)                                             5445 (1.2)      4462 (1.0)
  Fluid and electrolyte disorders (CCS‐55)                                                  7210 (1.6)      5407 (1.2)
  Deficiency and other anemia (CCS‐59)                                                      5159 (1.2)      3971 (0.9)
  Hypertension with complications and secondary hypertension (CCS‐99)                       6305 (1.4)      6216 (1.4)
  Coronary atherosclerosis and other heart disease (CCS‐101)                                31 034 (6.9)    21 222 (4.9)
  Nonspecific chest pain (CCS‐102)                                                          10 046 (2.2)    6855 (1.6)
  Cardiac dysrhythmias (CCS‐106)                                                            17 167 (3.8)    14 521 (3.3)
  Congestive heart failure (CCS‐108; non‐hypertensive)                                      46 340 (10.4)   37 766 (8.6)
  Acute cerebrovascular disease (CCS‐109)                                                   8825 (2.0)      7837 (1.8)
  Pneumonia (CCS‐122; except that caused by tuberculosis or sexually transmitted disease)   15 762 (3.5)    12 688 (2.9)
  Chronic obstructive pulmonary disease and bronchiectasis (CCS‐127)                        9949 (2.2)      8012 (1.8)
  Respiratory failure; insufficiency; arrest (CCS‐131; adult)                               8397 (1.9)      7288 (1.7)
  Gastrointestinal hemorrhage (CCS‐153)                                                     9592 (2.1)      8825 (2.0)
  Acute and unspecified renal failure (CCS‐157)                                             11 172 (2.5)    10 684 (2.4)
  Urinary tract infections (CCS‐159)                                                        9389 (2.1)      7232 (1.7)
  Fracture of neck of femur (CCS‐226; hip)                                                  4804 (1.1)      4002 (0.9)
  Complication of device; implant or graft (CCS‐237)                                        10 109 (2.3)    8191 (1.9)
  Complications of surgical procedures or medical care (CCS‐238)                            7680 (1.7)      6306 (1.4)

AMI indicates acute myocardial infarction; CCS, Clinical Classifications Software; and FY, fiscal years.
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![Median (interquartile range \[IQR\]) days to subsequent rehospitalizations within 1 year after discharge for index AMI.The median (IQR) days to recurrent AMI were 115 (34--230) in the 2009--2011 sample and 106 (31--217) in the 2012 to 2014 sample. AMI indicates acute myocardial infarction; CAD, coronary artery disease; CCS_101, Coronary atherosclerosis and other heart disease; CCS_102, Nonspecific chest pain; CCS_106, Cardiac dysrhythmias; CCS_108, Congestive heart failure; CCS_109, Acute cerebrovascular disease; CCS_122, Pneumonia; CCS_131, Respiratory failure; insufficiency; arrest; CCS_153, Gastrointestinal hemorrhage; CCS_157, Acute and unspecified renal failure; CCS_159, Urinary tract infections; CCS_2, Septicemia; CCS_226, Fracture of neck of femur; CCS_237, Complication of device; implant or graft; CCS_238, Complications of surgical procedures or medical care; CCS_50, Diabetes mellitus with complications; CCS_55, Fluid and electrolyte disorders; CCS_59, Deficiency and other anemia; CCS_99, Hypertension with complications and secondary hypertension; CCS, Clinical Classifications Software; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; and UTI, urinary tract infection](JAH3-9-e014907-g004){#jah34948-fig-0004}

Association Between Subsequent Hospitalizations and Recurrent AMI {#jah34948-sec-0021}
-----------------------------------------------------------------

Most of the 19 subsequent hospitalizations were associated with an increased recurrent AMI risk in the descriptive analysis without accounting for patient baseline risk of recurrent AMI (Table [3](#jah34948-tbl-0003){ref-type="table"}). The Cox model based on the 2009--2011 data identified 12 CCS‐specific subsequent hospitalizations significantly associated to recurrent AMI risk (Figure [5](#jah34948-fig-0005){ref-type="fig"}). These hospitalizations were septicemia (CCS‐2), diabetes mellitus with complications (CCS‐50), deficiency and other anemia (CCS‐59), hypertension with complications and secondary hypertension (CCS‐99), coronary atherosclerosis and other heart disease (CCS‐101), nonspecific chest pain (CCS‐102), congestive heart failure (CCS‐108), pneumonia (CCS‐122), chronic obstructive pulmonary disease and bronchiectasis (CCS‐127), gastrointestinal hemorrhage (CCS‐153), acute and unspecified renal failure (CCS‐157), and complication of device (implant or graft; CCS‐237). All these rehospitalizations except septicemia (CCS‐2) were associated with increased risk of recurrent AMI; septicemia (CCS‐2) was associated with a lower risk of recurrent AMI (Figure [5](#jah34948-fig-0005){ref-type="fig"}). The HRs ranged from 1.6 (95% CI, 1.55--1.70, heart failure \[CCS‐108\]) to 1.1 (95% CI, 1.04--1.25, pneumonia \[CCS‐122\]); the HR for septicemia (CCS‐2) was 0.6 (95% CI, 0.58--0.71; Figure [5](#jah34948-fig-0005){ref-type="fig"}).

###### 

Observed Association Between a Targeted CCS‐Specific Condition‐Related Subsequent Hospitalization and 1‐Year Recurrent AMI Based on a Single‐Variable Cox Regression Model

  Rehospitalization                                                                         FY 2009--2011       FY 2012--2014
  ----------------------------------------------------------------------------------------- ------------------- -------------------
  Septicemia (CCS‐2; except in labor)                                                       0.80 (0.72--0.89)   0.87 (0.78--0.97)
  Diabetes mellitus with complications (CCS‐50)                                             2.10 (1.85--2.37)   2.50 (2.18--2.86)
  Fluid and electrolyte disorders (CCS‐55)                                                  1.49 (1.31--1.68)   1.74 (1.51--2.01)
  Deficiency and other anemia (CCS‐59)                                                      1.87 (1.64--2.14)   1.97 (1.68--2.31)
  Hypertension with complications and secondary hypertension (CCS‐99)                       2.35 (2.11--2.62)   2.39 (2.13--2.69)
  Coronary atherosclerosis and other heart disease (CCS‐101)                                1.70 (1.61--1.80)   1.94 (1.82--2.08)
  Nonspecific chest pain (CCS‐102)                                                          1.79 (1.63--1.97)   1.89 (1.68--2.13)
  Cardiac dysrhythmias (CCS‐106)                                                            1.26 (1.16--1.37)   1.25 (1.13--1.38)
  Congestive heart failure (CCS‐108; non‐hypertensive)                                      2.12 (2.03--2.21)   2.00 (1.90--2.11)
  Acute cerebrovascular disease (CCS‐109)                                                   1.03 (0.90--1.18)   1.00 (0.86--1.17)
  Pneumonia (CCS‐122; except that caused by tuberculosis or sexually transmitted disease)   1.46 (1.33--1.59)   1.57 (1.42--1.73)
  Chronic obstructive pulmonary disease and bronchiectasis (CCS‐127)                        1.93 (1.75--2.13)   1.75 (1.55--1.97)
  Respiratory failure; insufficiency; arrest (CCS‐131; adult)                               1.54 (1.38--1.73)   1.28 (1.11--1.47)
  Gastrointestinal hemorrhage (CCS‐153)                                                     1.42 (1.28--1.58)   1.48 (1.32--1.67)
  Acute and unspecified renal failure (CCS‐157)                                             1.60 (1.45--1.76)   1.47 (1.31--1.63)
  Urinary tract infections (CCS‐159)                                                        1.37 (1.22--1.54)   1.35 (1.17--1.56)
  Fracture of neck of femur (CCS‐226; hip)                                                  1.40 (1.18--1.66)   1.26 (1.02--1.56)
  Complication of device; implant or graft (CCS‐237)                                        1.98 (1.80--2.17)   2.13 (1.91--2.37)
  Complications of surgical procedures or medical care (CCS‐238)                            0.90 (0.79--1.04)   1.03 (0.88--1.20)

AMI indicates acute myocardial infarction; CCS, Clinical Classifications Software; FY, fiscal years; and HR, hazard ratio.
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![Association between subsequent rehospitalizations and recurrent AMI after discharge for index AMI, accounting for baseline risk of recurrence.AMI indicates acute myocardial infarction; CAD, coronary artery disease; CCS, Clinical Classifications Software; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; and HTN, hypertension.](JAH3-9-e014907-g005){#jah34948-fig-0005}

![Association between at least 1 subsequent hospitalization and risk of recurrent AMI by patient baseline risk and age groups.AMI indicates acute myocardial infarction.](JAH3-9-e014907-g006){#jah34948-fig-0006}

Overall, 26.9% of patients in 2009--2011 and 22.5% of patients in 2012--2014 had at least 1 of the identified subsequent CCS‐specific hospitalizations significantly associated with increased risk of recurrent AMI. For the low‐, average‐, and high‐risk groups in the 2009--2011 sample, having at least 1 CCS‐specific hospitalization was associated with an increase in the risk of recurrent AMI by 210% (95% CI, 77%--149%), 73% (95% CI 66%--79%), and 43% (95% CI 34%--52%), respectively. The younger age group (65--74 years) in the average‐risk strata was most likely to have a recurrence with at least 1 CCS‐specific hospitalization (Figure [6](#jah34948-fig-0006){ref-type="fig"}, left panel). The findings were similar for the 2012--2014 cohort (Figure [6](#jah34948-fig-0006){ref-type="fig"}, right panel).

Discussion {#jah34948-sec-0022}
==========

In this study, we demonstrated that hospitalizations after AMI were associated with the risk of a subsequent AMI. Although patient baseline characteristics were also associated with the risk of a recurrent AMI, we showed that patient risk of recurrence was influenced by hospitalizations that occurred after discharge. Among the 12 rehospitalization categories identified in this study, 11 were associated with increased risk of recurrent AMI, with the increase in risk ranging from 14% (pneumonia) to 62% (heart failure). We found that patients who survived a hospitalization for septicemia had a lower risk of a recurrent AMI.

There are several potential explanations for the associations between subsequent hospitalizations and increased patient risk of recurrent AMI. It is possible that the hospitalization is a marker for the presence and severity of comorbidities. Sick patients tend to have more comorbidities[23](#jah34948-bib-0023){ref-type="ref"} and are more likely to be rehospitalized after AMI.[24](#jah34948-bib-0024){ref-type="ref"} We adjusted for baseline comorbidities, but information about the severity does not reside within the administrative codes in our Medicare database. Additionally, the hospitalizations may be a marker for postdischarge quality of care. Postdischarge care factors, such as continuity of care, type of care, and care providers, could impact AMI patient outcomes.[25](#jah34948-bib-0025){ref-type="ref"}, [26](#jah34948-bib-0026){ref-type="ref"}, [27](#jah34948-bib-0027){ref-type="ref"} Studies have identified associations between poor postdischarge care and subsequent hospitalizations,[28](#jah34948-bib-0028){ref-type="ref"}, [29](#jah34948-bib-0029){ref-type="ref"}, [30](#jah34948-bib-0030){ref-type="ref"} including recurrent AMI. Many subsequent hospitalizations identified by our study, including those for diabetes mellitus, anemia, hypertension, coronary atherosclerosis, chest pain, heart failure, pneumonia, chronic obstructive pulmonary disease and bronchiectasis, respiratory failure, gastrointestinal hemorrhage, renal failure, and complications of an implant or graft, have been individually identified as potential risk markers for recurrent AMI or major cardiovascular events in previous studies.[6](#jah34948-bib-0006){ref-type="ref"}, [8](#jah34948-bib-0008){ref-type="ref"}, [31](#jah34948-bib-0031){ref-type="ref"} Another possible explanation for our findings is that the hospitalization itself increased the risk. The reason for the hospitalization may have been associated with inflammation, a known contributor to AMI risk, or to other factors associated with AMI, such as stress or depression. It is also possible that the hospitalization led to the discontinuation of secondary preventive medications or the addition of medications to a patient\'s regimen, which may have resulted in nonadherence to the regimen.

The negative association of septicemia with recurrent AMI may represent a survivorship bias because patients who survived sepsis may have been healthier than those who died with sepsis and were therefore less likely to have a recurrent AMI. Our data showed that approximately 22% of AMI survivors rehospitalized for sepsis died during the sepsis hospitalization.

Our study, based on real‐world data, has several important characteristics. We focused on the first year after an initial AMI, a period that has the highest risk of recurrent AMI.[4](#jah34948-bib-0004){ref-type="ref"} Our findings provide real‐world empirical evidence of the importance of accounting for postdischarge rehospitalizations to help ensure better long‐term outcomes. We showed that patient risk stratification for recurrent AMI was a dynamic measure that could change immediately after discharge. The CCS categories allowed the grouping of similar medical conditions to provide hospitals and physicians a parsimonious, clinically meaningful, and practically useful composite measure of rehospitalizations. Such a composite measure could be used more easily than a traditional approach based on individual *ICD* diagnosis codes. The 12 subsequent hospitalizations identified in the study were based on the 285 CCS categories, which represent all principal diagnosis codes for rehospitalizations. These CCS categories are easy to collect and readily available at the time of discharge for the rehospitalization.

A model that combines rehospitalizations with patient baseline characteristics would allow hospitals and physicians to reevaluate patient risk for recurrent AMI throughout the first year and may help patients understand that their risk of recurrence depends not only on their baseline characteristics but also the sequence of rehospitalizations that occur after their initial AMI. The ability to identify individuals with the highest risk of recurrent AMI after a rehospitalization may aid in the provision of targeted, intensive, and higher‐quality longitudinal care after discharge. Additionally, insight regarding the long‐term risk of subsequent hospitalizations associated with recurrent AMI is important from a patient perspective as educating patients regarding their long‐term risk might provide an even stronger incentive to follow‐up and adhere to medications. Our study also provides evidence that hospitals and primary care physicians caring for patients with a history of AMI should be aware that subsequent hospitalizations can change patient risk of recurrent AMI.

Our study has several limitations. We considered only the first recurrent AMI and acknowledge that patients may experience multiple recurrent events, in which a recurrent event model can be fit. The subsequent hospitalizations identified in our study were based on the CCS categories, which represent multiple principal discharge diagnosis codes, while an individual rehospitalization only represents a single principal diagnosis code that could be more clinically important. We accounted for only inpatient rehospitalizations and did not consider outpatient care, observation stays, or emergency department visits. We treated subsequent rehospitalizations independently and acknowledge that some hospitalizations may have been related. Nevertheless, we found that the median tetrachoric correlation among these rehospitalizations was not high, indicating these rehospitalizations were not strongly related to each other. We did not address whether the association between a subsequent hospitalization and a recurrent AMI depended on the hospitalization‐free duration from an index AMI discharge to a rehospitalization, which could be clinically important. We restricted the 2011--2015 data to the first 10 diagnosis codes to align with the 2009--2010 data, which only contained 10 diagnosis codes. Accordingly, we may have missed some comorbidity information carried by the additional codes. Our study was limited by the availability of data resources, and therefore it did not incorporate information on medication adherence, nursing home stays, and home health services, which were associated with rehospitalizations and recurrent AMI in prior work.[32](#jah34948-bib-0032){ref-type="ref"}, [33](#jah34948-bib-0033){ref-type="ref"}, [34](#jah34948-bib-0034){ref-type="ref"} Moreover, we used comorbidity information from administrative data. These data lack detailed clinical information on patient functional status, left ventricular function, non--ST‐segment--elevation myocardial infarction, and ST‐segment elevation myocardial infarction, which could be important for assessing risk of recurrence and reducing measurement error.

In conclusion, patient risk of recurrent AMI changed on the basis of the occurrence of subsequent hospitalizations. Improving post--acute care to prevent unplanned rehospitalizations, especially those for chronic diseases, and extending the current focus on all‐cause 30‐day rehospitalizations to condition‐specific rehospitalizations beyond the 30‐day period are important for the secondary prevention of AMI. Moreover, there should be strong efforts to ensure that patients who experience these events have optimal secondary prevention strategies.
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